🧪 Beta — BiohacksAI is under active development. Data and features may change.
B
BiohacksAI
Evidence-Based Biohacking
BetaPatent Pending

JAK1

MOLECULAR TARGET

Tyrosine-protein kinase JAK1

59 compounds

JAK1 (Tyrosine-protein kinase JAK1) is targeted by 59 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting JAK1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1tofacitinib4.65104
2tozasertib4.3375
3ponatinib4.2670
4ruxolitinib4.2368
5ceritinib4.1965
6pi 1034.1764
7midostaurin3.8546
8nintedanib3.6136
9baricitinib3.5634
10tae 6843.4330
11fedratinib3.4029
12entrectinib3.1823
13dovitinib3.0921
14jnj 77066213.0921
15at 92833.0921
16upadacitinib3.0921
17lestaurtinib3.0420
18pacritinib3.0420
19filgotinib3.0420
20momelotinib2.8917
21r 4062.8316
22sotrastaurin2.7715
23ritlecitinib2.7715
24pha 6657522.7114
25apitolisib2.7114
26kw 24492.6413
27ast 4872.5612
28zotiraciclib2.5612
29motesanib2.4811
30deucravacitinib2.4811
31azd 14802.309
32reversine2.309
33vs 55842.309
34su 0148132.208
35rebastinib2.208
36decernotinib2.208
37gandotinib2.208
38cyc 1162.087
39tg100 1152.087
40cerdulatinib1.956
41itacitinib1.956
42delgocitinib1.956
43pf 038147351.795
44abrocitinib1.795
45bdb pf 06651600 us11111242 example 5 us9617258 example 50.691
46bdb asp 015k asp015k peficitinib0.691
47bdb chembl42389260.691
48bdb chembl44461020.691
49bdb e z 2 cyano n n dimethyl 3 5 1 1s 2r 2 methylcyclohexyl 1 6 dihydroimidazo 4 5 d0.691
50bdb pf 02384554 us10966980 example 8 us9035074 80.691

Showing top 50 of 59 compounds. Use the BiohacksAI search to explore all JAK1 modulators.

About JAK1 as a Drug Target

JAK1 (Tyrosine-protein kinase JAK1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 59 compounds with documented JAK1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

JAK1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.